GH and IGF-1 excess exerts many actions on the cardiovascular (CV) system, and CV comorbidities and disease (CVD) risk factors are common, especially in active acromegaly [3–5], but often persist after adequate treatment in patients with controlled disease [6–9]. This evidence concerns the gene GH1 and acromegaly.